Literature DB >> 22086004

Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application.

Jiye Yin1, Jianting Zhang.   

Abstract

Multidrug resistance-associated protein 1(MRP1/ABCC1) is the first identified member of ABCC subfamily which belongs to ATP-binding cassette (ABC) transporter superfamily. It is ubiquitously expressed in almost all human tissues and transports a wide spectrum of substrates including drugs, heavy metal anions, toxicants, and conjugates of glutathione, glucuronide and sulfate. With the advance of sequence technology, many MRP1/ABCC1 polymorphisms have been identified. Accumulating evidences show that some polymorphisms are significantly associated with drug resistance and disease susceptibility. In vitro reconstitution studies have also unveiled the mechanism for some polymorphisms. In this review, we present recent advances in understanding the role and mechanism of MRP1/ABCC1 polymorphisms in drug resistance, toxicity, disease susceptibility and severity, prognosis prediction, and Methods to select and predict functional polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086004      PMCID: PMC4297474          DOI: 10.3969/j.issn.1672-7347.2011.10.002

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  72 in total

1.  Predicting deleterious amino acid substitutions.

Authors:  P C Ng; S Henikoff
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

2.  Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome.

Authors:  Motofumi Tanaka; Taro Okazaki; Hideo Suzuki; James L Abbruzzese; Donghui Li
Journal:  Cancer       Date:  2010-10-04       Impact factor: 6.860

3.  Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma.

Authors:  Jing Zhao; Bing-Yun Yu; Dao-Yuan Wang; Jin-E Yang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

4.  Role of transmembrane segment 5 and extracellular loop 3 in the homodimerization of human ABCC1.

Authors:  Youyun Yang; Wei Mo; Jian-Ting Zhang
Journal:  Biochemistry       Date:  2010-12-02       Impact factor: 3.162

5.  ABCC1 polymorphism Arg723Gln (2168G> A) is associated with lung cancer susceptibility in a Chinese population.

Authors:  Ji-Ye Yin; Li-Fang Han; Qiong Huang; Xiao-Jing Xu; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-09       Impact factor: 2.557

Review 6.  Structural, mechanistic and clinical aspects of MRP1.

Authors:  D R Hipfner; R G Deeley; S P Cole
Journal:  Biochim Biophys Acta       Date:  1999-12-06

7.  ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcript.

Authors:  Marina Pajic; Jayne Murray; Glenn M Marshall; Susan P C Cole; Murray D Norris; Michelle Haber
Journal:  Pharmacogenet Genomics       Date:  2011-05       Impact factor: 2.089

8.  Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.

Authors:  J Wijnholds; E C deLange; G L Scheffer; D J van den Berg; C A Mol; M van der Valk; A H Schinkel; R J Scheper; D D Breimer; P Borst
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

9.  Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis.

Authors:  Andrea Mafficini; Myriam Ortombina; Isabelle Sermet-Gaudelius; Patrick Lebecque; Teresinha Leal; Patrizia Iansa; Gregory Reychler; Karin Dahan; Xaviers Pepermans; Gerard Lenoir; Anissa Leonard; Claudio Sorio; Baroukh Assael; Paola Melotti
Journal:  J Cyst Fibros       Date:  2011-03-24       Impact factor: 5.482

10.  Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors.

Authors:  Neeltje Steeghs; Hans Gelderblom; Judith Wessels; Ferry A L M Eskens; Natasja de Bont; Johan W R Nortier; Henk-Jan Guchelaar
Journal:  Invest New Drugs       Date:  2009-11-19       Impact factor: 3.850

View more
  16 in total

1.  miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1.

Authors:  Huanxin Liu; Xiaoxia Wu; Jie Huang; Juan Peng; Linlang Guo
Journal:  Int J Exp Pathol       Date:  2015-06-24       Impact factor: 1.925

2.  The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.

Authors:  Ke-Tao Jin; Ze-Bei Lu; Jie-Qing Lv; Jun-Gang Zhang
Journal:  RNA Biol       Date:  2020-03-15       Impact factor: 4.652

3.  Extracellular Vesicles in Chemoresistance.

Authors:  Gabriele De Rubis; Mary Bebawy
Journal:  Subcell Biochem       Date:  2021

Review 4.  Role of microRNAs in the development of hepatocellular carcinoma and drug resistance.

Authors:  Lucas Tricoli; Suresh Niture; Uche Chimeh; Habtom Ressom; Deepak Kumar
Journal:  Front Biosci (Landmark Ed)       Date:  2019-01-01

5.  Abcc1 and Ggt5 support lymphocyte guidance through export and catabolism of S-geranylgeranyl-l-glutathione.

Authors:  Antonia E Gallman; Finn D Wolfreys; David N Nguyen; Moriah Sandy; Ying Xu; Jinping An; Zhongmei Li; Alexander Marson; Erick Lu; Jason G Cyster
Journal:  Sci Immunol       Date:  2021-06-04

6.  Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients.

Authors:  Ji-Ye Yin; Qiong Huang; Ying-Chun Zhao; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

Review 7.  Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes.

Authors:  Willy Albert Flegel; Kshitij Srivastava; Tristan Michael Sissung; Barry Ronald Goldspiel; William Douglas Figg
Journal:  Vox Sang       Date:  2020-09-30       Impact factor: 2.996

Review 8.  Detection approaches for multidrug resistance genes of leukemia.

Authors:  Ying Du; Baoan Chen
Journal:  Drug Des Devel Ther       Date:  2017-04-18       Impact factor: 4.162

9.  Drug resistance and combating drug resistance in cancer.

Authors:  Xuan Wang; Haiyun Zhang; Xiaozhuo Chen
Journal:  Cancer Drug Resist       Date:  2019-06-19

10.  The Structure and Mechanism of Drug Transporters.

Authors:  Arthur G Roberts
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.